Back to top

Tale of the Tape

Genomic Health, Inc. Enters Oversold Territory
September 12, 2012

GHDX

 ZacksTrade Now

Genomic Health, Inc.’s (GHDX - Analyst Report) share price has entered into oversold territory with a stochastic value of 11.3322. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to 18 cents per share. Genomic Health, Inc. is a Zacks #2 Rank (“Buy”) company.

 

Please login to Zacks.com or register to post a comment.